No items found

New Models Predict Risk for Ventilation, Death From COVID-19

Share on facebook
Share on twitter
Share on linkedin
Share on email

Key Takeaways

  • Two new models help predict which hospitalized COVID-19 patients will require mechanical ventilation or die.
  • The 4 factors independently associated with mechanical ventilation were diabetes mellitus, oxygen saturation to fraction of inspired oxygen ratio, C-reactive protein, and lactate dehydrogenase.
  • 10 factors were predictive of in-hospital mortality age, male sex, coronary artery disease, diabetes mellitus, chronic statin use, oxygen saturation to fraction of inspired oxygen ratio, body mass index, neutrophil-to-lymphocyte ratio, platelet count, and procalcitonin.

HealthDay News–Two new models help predict which hospitalized COVID-19 patients will require mechanical ventilation or die, according to a study published in EClinicalMedicine.

Christopher J. Nicholson, Ph.D., from Massachusetts General Hospital in Boston, and colleagues used electronic medical records to retrospectively identify 1042 patients with COVID-19 (median age, 64 years; 56.8% male) admitted to Mass General Brigham hospitals before May 19, 2020, to determine risk factors on admission (including comorbidities, vital signs, and initial laboratory assessment) associated with the need for ventilation and in-hospital mortality. The Ventilation in COVID Estimator (VICE) and Death in COVID Estimator (DICE) risk scores were derived from 578 patients and validated among 464 patients.

The researchers identified 4 factors independently predictive for mechanical ventilation (diabetes mellitus, oxygen saturation to fraction of inspired oxygen ratio, C-reactive protein, and lactate dehydrogenase) and 10 factors predictive of in-hospital mortality (age, male sex, coronary artery disease, diabetes mellitus, chronic statin use, oxygen saturation to fraction of inspired oxygen ratio, body mass index, neutrophil-to-lymphocyte ratio, platelet count, and procalcitonin). The VICE and DICE risk scores performed with C-statistics of 0.84 and 0.91, respectively. The chronic use of a statin was associated with protection against death due to COVID-19.

“The risk scores developed in this study may help clinicians more appropriately determine which COVID-19 patients will need to be managed with greater intensity,” the authors write.

Abstract/Full Text

Leave a Reply

Your email address will not be published. Required fields are marked *

Want to continue reading this article?

Log in to your account